Comprehensive analysis of suppressor of cytokine signaling proteins in human breast Cancer.
Comprehensive analysis of suppressor of cytokine signaling proteins in human breast Cancer.
复制标题
人乳腺癌细胞因子信号蛋白抑制因子的综合分析
DOI:
10.1186/s12885-021-08434-y
复制
发表时间:
2021-06-13
期刊:
影响因子:
3.8
通讯作者:
Rixiati Y
中科院分区:
文献类型:
--
作者:
Sun M;Tang C;Liu J;Jiang W;Yu H;Dong F;Huang C;Rixiati Y
Abnormal expression of suppressor of cytokine signaling (SOCS) proteins regulates tumor angiogenesis and development in cancers. In this study, we aimed to perform a comprehensive bioinformatic analysis of SOCS proteins in breast invasive carcinoma (BRCA). The gene expression, methylation level, copy number, protein expression and patient survival data related to SOCS family members in BRCA patients were obtained from the following databases: Oncomine, The Cancer Genome Atlas (TCGA), Genotype-Tissue Expression (GTEx), Human Protein Atlas (HPA), Gene Expression Profiling Interactive Analysis (GEPIA), PCViz, cBioPortal and Kaplan-Meier plotter. Correlation analyses, identification of interacting genes and construction of regulatory networks were performed by functional and pathway enrichment analyses, weighted gene coexpression network analysis (WGCNA) and gene set enrichment analysis (GSEA). Data related to 1109 BRCA tissues and 113 normal breast tissue samples were extracted from the TCGA database. SOCS2 and SOCS3 exhibited significantly lower mRNA expression levels in BRCA tissues than in normal tissues. BRCA patients with high mRNA levels of SOCS3 (p < 0.01) and SOCS4 (p < 0.05) were predicted to have significantly longer overall survival (OS) times. Multivariate analysis showed that SOCS3 was an independent prognostic factor for OS. High mRNA expression levels of SOCS2 (p < 0.001), SOCS3 (p < 0.001), and SOCS4 (p < 0.01), and a low expression level of SOCS5 (p < 0.001) were predicted to be significantly associated with better recurrence-free survival (RFS). Multivariate analysis showed that SOCS2 was an independent prognostic factor for RFS. Lower expression levels of SOCS2 and SOCS3 were observed in patients with tumors of more advanced clinical stage (p < 0.05). Functional and pathway enrichment analyses, together with WGCNA and GSEA, showed that SOCS3 and its interacting genes were significantly involved in the JAK-STAT signaling pathway, suggesting that JAK-STAT signaling might play a critical role in BRCA angiogenesis and development. Western blot results showed that overexpression of SOCS3 inhibited the activity of the JAK-STAT signaling pathway in vitro. SOCS family proteins play a very important role in BRCA. SOCS3 may be a prognostic factor and SOCS2 may be a potential therapeutic target in breast cancer. The online version contains supplementary material available at 10.1186/s12885-021-08434-y.
登录
查看更多内容
影响因子:
5.7
作者:
Chikuma S;Kanamori M;Mise-Omata S;Yoshimura A
通讯作者:
Yoshimura A
DOI:
10.4161/jkst.24053
发表时间:
2013-07-01
期刊:
JAK-STAT
影响因子:
--
作者:
Inagaki-Ohara K;Kondo T;Ito M;Yoshimura A
通讯作者:
Yoshimura A
影响因子:
7
作者:
Harrow J;Frankish A;Gonzalez JM;Tapanari E;Diekhans M;Kokocinski F;Aken BL;Barrell D;Zadissa A;Searle S;Barnes I;Bignell A;Boychenko V;Hunt T;Kay M;Mukherjee G;Rajan J;Despacio-Reyes G;Saunders G;Steward C;Harte R;Lin M;Howald C;Tanzer A;Derrien T;Chrast J;Walters N;Balasubramanian S;Pei B;Tress M;Rodriguez JM;Ezkurdia I;van Baren J;Brent M;Haussler D;Kellis M;Valencia A;Reymond A;Gerstein M;Guigó R;Hubbard TJ
通讯作者:
Hubbard TJ
DOI:
10.1073/pnas.0601638103
发表时间:
2006-05-16
影响因子:
11.1
作者:
Bullock, Alex N.;Debreczeni, Judit E.;Knapp, Stefan
通讯作者:
Knapp, Stefan
DOI:
10.1152/ajpheart.00570.2012
发表时间:
2013-03-01
影响因子:
4.8
作者:
Dhar, Kajari;Rakesh, Kriti;Agrawal, Devendra K.
通讯作者:
Agrawal, Devendra K.